Live Donors of Tissue

Chapter

Abstract

Donations by living donors include bone, cord blood, amniotic membrane, ophthalmic limbal stem cells and heart valves. The latter may include heart lung block recipients who then donate their hearts. Allograft haemopoietic stem cell donors of bone marrow and peripheral blood stem cells are also clearly living donors but are not dealt with in this chapter because their donations are not banked but used directly after donation. Living tissue and cell donors dealt with in this chapter, and the circumstances of their procurement, are summarised in Table 1.1.

Keywords

Femoral Head Cord Blood Amniotic Membrane Sickle Cell Trait Cord Blood Transplantation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Commission Directive 2006/17/EC of 8 February 2006 implementing Directive 2004/23/EC of the European Parliament and of the Council as regards certain technical requirements for the donation, procurement and testing of human tissues and cells. Official Journal of the European Union L 38/40 09/02/2006.Google Scholar
  2. 2.
    Pink F, Warwick RM, Purkis J, Pearson J (2006) Donor exclusion in the national blood service tissue services living bone donor programme. Cell Tissue Bank 7(1):11–21. DOI: 10.1007/s10561-005-2362-2PubMedCrossRefGoogle Scholar
  3. 3.
    Commission Directive 2006/86/EC of 24 October 2006 implementing Directive 2004/23/EC of the European Parliament and of the Council as regards traceability requirements, notification of serious adverse reactions and events, and certain technical requirements for the coding, processing, preservation, storage and distribution of human tissues and cells. Official Journal of the European Union L 294/32 25/10/2006.Google Scholar
  4. 4.
    Saw VP, Minassian D, Dart JK, Ramsay A, Henderson H, Poniatowski S, Warwick RM, Cabral S, the Amniotic Membrane Tissue User Group (AMTUG) (2007) Amniotic membrane transplantation for ocular disease: a review of the first 233 cases from the UK User Group. Br J Ophthalmol 91:1042–1047PubMedCrossRefGoogle Scholar
  5. 5.
    Smythe J, Armitage S, McDonald D, Pamphilon D, Gutteridge M, Brown J, Green A, Brown C, Warwick RM, Lankester A, Fehily D, Contreras M, Navarrete C, Watt SM (2007) Directed sibling cord blood banking for transplantation: the 10-Year experience in the national blood service in England. Stem Cells 25:2087–2093PubMedCrossRefGoogle Scholar
  6. 6.
    Royal College of Obstetricians and Gynaecologists Scientific Advisory Committee, Opinion Paper 2, June 2006Google Scholar
  7. 7.
    Ruiz-Arguelles GJ, Reyes-Nunez V, Garces-Eisele J, Warwick RM, McKenna L, Ruiz-Reyes G, Granados J, Mercado-Diaz MA (2005) Acquired haemoglobin S trait in an adult patient with secondary acute myelogenous leukemia allografted with matched unrelated umbilical Cord blood cells. Haema 8(3):492–496Google Scholar
  8. 8.
    Eastlund T, Strong DM (2004) Infectious disease transmission through tissue transplantation. In: Phillips GO, Kearney JN, Strong DM, Von Verson R, Nather A (eds) Advances in tissue banking, vol 7. Scientific Publishing, Singapore.Google Scholar
  9. 9.
    Wang S, Zinderman C, Wise R, Braun M (2007) Infections and human tissue transplants: Review of FDA MedWatch reports 2001-2004. Cell Tissue Bank 8(3):211–219. Feb 2007. (E-pub. DOI 10.1007/S10561-007-9034-3)PubMedCrossRefGoogle Scholar
  10. 10.
    Directive 2004/23/EC of the European Parliament and of the Council of 31 March 2004 on setting standards for quality and safety in the donation, procurement, processing, preservation, storage and distribution of human tissues and cells. Official Journal of the European Union L 102/48 07/04/2004.Google Scholar
  11. 11.
    Zou S., Dodd RY, Stramer SL, Strong DM for the Tissue Safety Study Group (2004) Probability of Viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States. N Engl J Med 351(8):751–759PubMedCrossRefGoogle Scholar
  12. 12.
    Brant LJ, Davison KL (2008) Infections detected in English surgical bone and deceased donors (2001–2006) and estimated risk of undetected hepatitis B and hepatitis C virus. Vox Sang 95:272–279PubMedCrossRefGoogle Scholar
  13. 13.
    Guidelines for the Blood Transfusion Services in the United Kingdom (2005) 7th edn. TSO (The Stationary Office), London. PO Box 29, Norwick, NR31 1GN http://www.tsoshop.co.uk
  14. 14.
    Sugihara S, Van Ginkel AD, Jiya TU, Van Royen BJ, Van Diest PJ, Wuisman PIJM (1999) Histopathology of retrieved allografts of the femoral head. J Bone Joint Surg 8(B):336–341CrossRefGoogle Scholar
  15. 15.
    Palmer SH, Gibbons CLMH, Athansou NA (1999) The pathology of bone allograft. J Bone Joint Surg 81(B):333–335CrossRefGoogle Scholar
  16. 16.
    Gartner HV, Seidl C, Luckenbach C, Schumm, G, Seifried E, Ritter H, Bültmann B (1996) Brief report: genetic analysis of a sarcoma accidentally transplanted from a patient to a surgeon. N Engl J Med 335:1494–1497.PubMedCrossRefGoogle Scholar
  17. 17.
    Gugel EA, Sanders ME (1986) Needle-stick transmission of human colonic adenocarcinoma. N Engl J Med 315:1487PubMedCrossRefGoogle Scholar
  18. 18.
    Lomas R, Drummond O, Kearney J.N (2000) Processing of whole femoral head allografts: a method for improving clinical efficacy and safety. CATB 1:193–200Google Scholar
  19. 19.
    Sanzen L, Carlsson A (1997) Transmission of human T-cell lymphotrophic virus type 1 by a deep-frozen bone allograft. Acta Orthop Scand 68(1):72–74PubMedCrossRefGoogle Scholar
  20. 20.
    Pruss A, Kao M, von Verson R, Pauli G (1999) Virus safety of avital bone tissue transplants: evaluation of sterilization steps of spongiosa cuboids using a peracetic acid methanol mixture. Biologicals 27:195–201PubMedCrossRefGoogle Scholar
  21. 21.
    Pruss A, Baumann B, Seibold M, Kao M, Tinteinot K, von Verson R, Radtke H, Dorner T, Pauli G, Gobel UB (2001) Validation of the sterilization procedure of allogeneic avital bone transplants using peracetic ethanol. Biologicals 29:59–66PubMedCrossRefGoogle Scholar
  22. 22.
    Fehily D, Delvecchio C, DiCiacco P, Femaro C (2007) The EUSTITE Project: working towards harmonised implementation of European regulation of tissue and cells. Organs Tissues Cells 10(1):31–36.Google Scholar
  23. 23.
    Soldan K, Sinka K (2003) Evaluation of the de-selection of men who have had sex with men from blood donation in England. Vox Sang 84:265–273PubMedCrossRefGoogle Scholar
  24. 24.
    Nicoll A, McGarrigle C, Brady AR, Ades AE, Tookey P, Duong T, Mortimer J, Cliffe S, Goldberg D, Tappin D, Hudson C, Peckham C (1998) Epidemiology and detection of HIV-1 among pregnant women in the United Kingdom: results from national surveillance 1988-96. BMJ 316(7127):253–258PubMedCrossRefGoogle Scholar
  25. 25.
    Tedder RS, Zuckerman MA, Goldstone AH, Hawkins AE, Fielding A, Briggs EM, Irwin D, Blair S, Gorman AM, Patterson KG, Linch DC, Heptonstall J, Brink NS (1995) Hepatitis B transmission from contaminated cryopreservation tank. Lancet 346:137–140PubMedCrossRefGoogle Scholar
  26. 26.
    Ohto H, Terazawa S, Sasaki N, Hino K, Ishiwata C, Kako M, Ujiie N, Endo C, Matsui A, Okamoto H, Mishiro S, for The Vertical Transmission of Hepatitis C Virus Collaborative Study Group (1994) Transmission of hepatitis virus from mothers to infants. N Engl J Med 330:744–750PubMedCrossRefGoogle Scholar
  27. 27.
    Dore GJ, Kaldor JM, McCaughan W (1997) Systemic review of role of polymerase chain reaction in defining infectiousness among people infected with hepatitis C virus. BMJ 315:333–337PubMedCrossRefGoogle Scholar
  28. 28.
    Sullivan MT, Williams AE, Fang C, Grandinetti T, Poieszbj, Ehrlich GD (1991) The American Red Cross HTLV-I/II collaborative study. Transmission of human T-lymphotropic virus types I and II by blood transfusion. A retrospective study of recipients of blood components (1993 through 1988). Arch Intern Med 151:2043–2048PubMedCrossRefGoogle Scholar
  29. 29.
    Okochi K, Sato H, Hinuma Y (1984) A retrospective study on transmission of adult T cell leukaemia virus by blood transfusion: seroconversion in recipients. Vox Sang 46:245–253PubMedCrossRefGoogle Scholar
  30. 30.
    Nightingale S, Orton D, Ratcliffe D, Skidmore S, Tosswill J, Desselberger U (1993) Antenatal survey of seroprevalence of HTLV-I infections in the West Midlands, England. Epidemiol Infect 110:379–387PubMedCrossRefGoogle Scholar
  31. 31.
    Tosswill JHC, Ades AE, Peckham C, Mortimer PP, Weber JN (1990) Infection with human T cell leukaemia/lymphoma virus type I in patients attending an antenatal clinic in London. BMJ 301:95–96PubMedCrossRefGoogle Scholar
  32. 32.
    Luca di A, Piattelli A, Artese L, Favia G, Patel S, Saunders N, Porter SR, Scully CM, Ngui SL, Teo CG (1997) Human herpesvirus 8 variants in sarcoid tissues. Lancet 350:1655–1661CrossRefGoogle Scholar
  33. 33.
    Regamey N, Tamm M, Wernli M, Witschi A, Thiel G, Cathomas G, Erb P (1998) Transmission of herpesvirus 8 infection from renal transplant donors to recipients. N Engl J Med 339:1358–1363PubMedCrossRefGoogle Scholar
  34. 34.
    Ho M (1998) Human herpes virus 8-Let the transplant physician beware. N Engl J Med 339:1391–1392PubMedCrossRefGoogle Scholar
  35. 35.
    Sperling RS, Shapiro DE, Coombs RW, Todd JA, Herman SA, McSherry GD, O’Sullivan MJ, Van Dyke RB, Jiminez E, Rouzioux C, Flynn PM, Sullivan JL (1996) Maternal viral load, Zidovidine treatment and the risk of transmission of HIV-1 from mother to infant. N Engl J Med 335:1621–1629PubMedCrossRefGoogle Scholar
  36. 36.
    Ghandi MJ, Strong, DM (2007) Donor derived malignancy following transplantation: a review. CATB 8(4):267–286, Epub 2007 Apr 12Google Scholar
  37. 37.
    Lo YM, Lo ES, Watson N, Noakes L, Sargent IL, Thilaganethan B, Wainscoat JS (1996) Two way cell traffic between mother and fetus: biologic and clinical implications. Blood 88:4390–4395PubMedGoogle Scholar
  38. 38.
    Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA (1996) Male progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci USA 93:705–708PubMedCrossRefGoogle Scholar
  39. 39.
    Artlett CM, Smith JB, Jimenez SA (1998) Identification of foetal DNA and Cells in skin lesions from women with systemic sclerosis. N Engl J Med 338:1186–1191PubMedCrossRefGoogle Scholar
  40. 40.
    Nelson JL, Furst DE, Maloney, Gooley T, Evans PC, Smith A, Bean MA, Ober C, Bianchi DW (1998) Microchimerism and HLA compatible relationships of pregnancy in scleroderma. Lancet 351:559–562PubMedCrossRefGoogle Scholar
  41. 41.
    Hutchinson DL, Turner JH, Schlesinger ER (1971) Persistence of donor cells in neonates after foetal and exchange transfusion. Am J Obstet Gynaecol 109:281–284Google Scholar
  42. 42.
    Bonney EA, Matzinger P (1997)_ The maternal immune system's interaction with circulating foetal cells. J Immunol 158:40–47PubMedGoogle Scholar
  43. 43.
    Catlin EA, Roberts JD, Rodrigo E, Preffer FI, Ferry JA, Kelliher AS, Atkins L, Weinstein HJ (1999) Transplancental transmission of natural-killer-cell lymphoma. N Engl J Med 341(2):85–91PubMedCrossRefGoogle Scholar
  44. 44.
    Fraser CJ, Hirsch BA, Dayton V, Creer MH, Neglia JP, Wagner JE, Baker KS (2005) First report of donor cell-derived acute leukaemia as a complication of umbilical cord blood transplantation. Blood 106(13):4377–4380, Epub 2005 Aug 23.PubMedCrossRefGoogle Scholar
  45. 45.
    Nagamura-Inoue T, Kodo H, Takahashi TA, Mugishima H, Tojo A, Asano S (2007) Four cases of donor cell-derived AML following unrelated cord blood transplantation for adult patients: experiences of the Tokyo Cord Blood Bank. Cytotherapy 9(8):727–728PubMedCrossRefGoogle Scholar
  46. 46.
    Sarugaser ER, Lickorish D, Bash D, Hosseini M, Davies JE (2005) Human Umbilical Perivascular (HUC PV) cells: a source of mesenchymal progenitors. Stem Cells 23:220–229PubMedCrossRefGoogle Scholar

Copyright information

© Springer Netherlands 2010

Authors and Affiliations

  1. 1.Consultant Specialist for Tissue ServicesNHSBT Tissue ServicesLondonUK

Personalised recommendations